Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10020175
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10020175
Fusion event
HBV-FRK integration
Validated
No
Detection method
VirusScan
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2016
PubMed ID
27339696
Virus Sequence
Virus name
HBV
Reference genome
NC_003977.1
Start
1163
End
2259
Orient
+
Integrated sequence
GTCAGGTCTCTGCCAAGTGTTTGCTGACGCAACCCCCACGGGTTGGGGCTTGGCCATAGGCCATCGGCGCATGCGTGGAACCTTTGTGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCAGCTTGTTTTGCTCGCAGCCGGTCTGGAGCGAAACTTATCGGAACCGACAACTCAGTTGTCCTCTCTCGGAAATACACCTCCTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCCTGCGCGGGACGTC
Host Sequence
Chromosome
chr6
Cytoband
q22.1
Reference genome
GRCh37/hg19
Start
116271467/115950304 (Hg38)
End
116272515/115951352 (Hg38)
Orient
+
Location type
Intronic
Target gene
FRK
miRNAs that regulate target gene
hsa-mir-335-5p
;
hsa-mir-6867-5p
;
hsa-mir-5682
;
hsa-mir-9-3p
;
hsa-mir-6832-5p
;
hsa-mir-4732-5p
;
hsa-mir-6499-3p
;
hsa-mir-5584-5p
;
hsa-mir-4519
;
hsa-mir-29c-3p
;
hsa-mir-29b-3p
;
hsa-mir-29a-3p
;
hsa-mir-6873-5p
;
hsa-mir-4302
;
hsa-mir-6871-3p
;
hsa-mir-4422
;
hsa-mir-6835-3p
;
hsa-mir-129-5p
;
hsa-mir-3680-3p
;
hsa-mir-557
;
hsa-mir-507
;
hsa-mir-450b-5p
;
hsa-mir-6788-5p
;
hsa-mir-30c-2-3p
;
hsa-mir-30c-1-3p
;
hsa-mir-8085
;
hsa-mir-6731-5p
;
hsa-mir-4714-3p
;
hsa-mir-6878-5p
;
hsa-mir-6871-5p
;
hsa-mir-4282
;
hsa-mir-1261
;
hsa-mir-151a-3p
;
hsa-mir-891a-3p
;
hsa-mir-3688-5p
;
hsa-mir-4463
;
hsa-mir-4499
;
hsa-mir-1243
;
hsa-mir-186-5p
;
hsa-mir-3133
;
hsa-mir-6892-5p
;
hsa-mir-203a-3p
;
hsa-mir-6730-5p
;
hsa-mir-7843-5p
;
hsa-mir-6879-5p
;
hsa-mir-6735-5p
;
hsa-mir-4632-5p
;
hsa-mir-4436b-3p
;
hsa-mir-3974
;
hsa-mir-3646
;
hsa-mir-8077
;
hsa-mir-7160-5p
;
hsa-mir-4663
;
hsa-mir-6761-5p
;
hsa-mir-7853-5p
;
hsa-mir-105-5p
;
hsa-mir-4728-3p
;
hsa-mir-607
;
hsa-mir-4435
;
hsa-mir-488-3p
;
hsa-mir-3671
;
hsa-mir-503-3p
;
hsa-mir-31-5p
;
hsa-mir-3922-3p
;
hsa-mir-3176
;
hsa-mir-3190-5p
;
hsa-mir-6837-5p
;
hsa-mir-4685-5p
;
hsa-mir-4692
;
hsa-mir-4514
;
hsa-mir-6715b-5p
;
hsa-mir-4269
;
hsa-mir-4742-5p
;
hsa-mir-4698
;
hsa-mir-8063
;
hsa-mir-3187-3p
;
hsa-mir-4529-5p
;
hsa-mir-5191
;
hsa-mir-6847-3p
;
hsa-mir-490-5p
;
hsa-mir-195-3p
;
hsa-mir-16-2-3p
;
hsa-mir-6876-5p
;
hsa-mir-4476
;
hsa-mir-4662a-5p
;
hsa-mir-103b
;
hsa-mir-3688-3p
;
hsa-mir-8076
;
hsa-mir-450a-1-3p
;
hsa-mir-2110
;
hsa-mir-6883-3p
;
hsa-mir-3147
;
hsa-mir-4425
;
hsa-mir-4694-5p
;
hsa-mir-6780b-5p
;
hsa-mir-4725-3p
;
hsa-mir-4271
;
hsa-mir-6739-5p
;
hsa-mir-6733-5p
;
hsa-mir-3153
;
hsa-mir-4668-5p
;
hsa-mir-711
;
hsa-mir-4738-3p
;
hsa-mir-454-5p
;
hsa-mir-3938
;
hsa-mir-3654
;
hsa-mir-4661-5p
;
hsa-mir-541-5p
;
hsa-mir-522-3p
;
hsa-mir-224-3p
;
hsa-mir-4694-3p
;
hsa-mir-548f-3p
;
hsa-mir-548e-3p
;
hsa-mir-548az-3p
;
hsa-mir-548ar-3p
;
hsa-mir-548a-3p
;
hsa-mir-1248
;
hsa-mir-1237-3p
;
hsa-mir-4529-3p
;
hsa-mir-7850-5p
;
hsa-mir-4520-2-3p
;
hsa-mir-384
;
hsa-mir-7975
;
hsa-mir-4520-3p
;
hsa-mir-5571-3p
;
hsa-mir-6877-3p
;
hsa-mir-6819-3p
Nearest miRNA
hsa-mir-10398/Upstream/9166084; hsa-mir-1202/Downstream/3117695;
Nearest TSS
ENST00000381078/Upstream/316113;
ENST00000417846/Downstream/109406;
Nearest CpG islands
None/Target,
chr6-CpG: 120/Upstream/1606609
,
chr6-CpG: 74/Downstream/149158
Nearest cancer related gene
FRK
(TSG, No orient, 0)
Upstream sequence
gtaaaataaaaccataatgagataatactgcacatctgccacaatggataacatcttcaaaagattaacaattttaattggaaaaaaatattgggaagta
Downstream sequence
tatatgaagtaagtattgcaattattcttccccatttcatagGAATTCCTTTTACTCAAAGGAATAGGTAACAAGTTGTGTGACCTATAATAGATGTTCT
Target sequence
gaatctacagggaacttaaacaaatttacaagaaataaaaaccatcaaaaagtgggcaaaggatatgaacagacacttttcaaaagaagacattcatgcagtcaacaaatatatgaaaaaaagctcatcatcactagagaaatccaaaccaaaaccacaatgagatagcatgtcatgtcagttagaatgggatcattaaaaagtcaggaaacaacagatgctggagaggatgtggagaaagaggaatgcttttac
Reference
Cao, S., et al.Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep,2016, 6: 28294.
Sample Information
×
Sample name
TCGA-BW-A5NP-01A-11R-A27V-07
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate